Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants
ConditionPreterm Infant
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-48
SponsorKorea University Anam Hospital
About this trial
This is a prospective observational study investigating the impact of NIV-NAVA on short-term clinical outcomes and long-term neurodevelopment in very preterm infants.
Eligibility criteria
Qualifiers
Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation
Preterm infants who require respiratory support within the first 48 hours of life
Disqualifiers
Preterm infants who die within the first 48 hours of life
Preterm infants who do not require any respiratory support within the first 48 hours of life.
Preterm infants with congenital anomalies affecting the lungs, heart, or other organs that could influence breathing
Infants whose parents do not consent to participate in the study
Trial design
Treatments tested in this trial
- Non-invasive NAVA
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov